Company: ACBM
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001640334-25-001279
Chunk: 21

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 21
---
U asset $39,755  $52,233    June 30,  December 31, Operating lease liabilities 2024  2023 Current portion $26,105  $25,335 Non-current portion  13,650   26,898 Total $39,755  $52,233  Future minimum lease payments under operating leases at June 30, 2024, were as follows: Remainder of 2024 $13,890 2025  27,780 Thereafter  - Total  41,670 Less Imputed interest  (1,915)Operating lease liabilities $39,755  The Company recognized total lease expenses of $13,890 and $13,140 for the six months ended June 30, 2024 and 2023, respectively and $6,945 and $6,570 for the three months ended June 30, 2024 and 2023, respectively.

NOTE 6 - SUBSEQUENT EVENTS The Company has evaluated subsequent events that have occurred after the date of the balance sheet through the date of the issuance of these unaudited financial statements and determined that no subsequent event requires recognition or disclosure to the unaudited financial statements.

 10Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in this report. This discussion contains forward-looking statements that involve risks, uncertainties and assumptions. See “Forward-Looking Statements.”

Overview

Since January 30, 2017, following a change of control, we have been engaged in the business of developing and marketing nutritional products that promote wellness and a healthy lifestyle. Our business has involved the purchase of products from three suppliers in Taiwan and the sale of these products to four unrelated customers, two of which accounted for all of our sales in the year ended December 31, 2022 and 91.7% of sales in the year ended December 31, 2021. We did not have any sales during the second and third quarters of 2022 and we have not had any sales subsequent to the December 31, 2022 through the date of this report and as of the date of this report we do not have any orders for products.